Evidence map›Paper›PMID 38900954›Full record

ArticleDiabetes2024

Lipodystrophy Prevalence, "Lipodystrophy-Like Phenotypes," and Diagnostic Challenges.

Baris Akinci, Julia von Schnurbein, David Araujo-Vilar, Martin Wabitsch, Elif A Oral

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Baris AkinciDokuz Eylul University Health Campus Technopark, Dokuz Eylul University, Izmir, Turkey.ORCID 0000-0002-8634-4845
Julia von SchnurbeinDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Centre for Rare Endocrine Disorders, Ulm University Medical Centre, Ulm, Germany.
David Araujo-VilarThyroid and Metabolic Diseases Unit-Molecular Pathology of Rare Diseases Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, Health Research Institute of Santiago de Compostela-Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, Santiago, Spain.ORCID 0000-0003-2852-7851
Martin WabitschDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Centre for Rare Endocrine Disorders, Ulm University Medical Centre, Ulm, Germany.
Elif A OralMetabolism, Endocrinology and Diabetes Division, Department of Internal Medicine, Caswell Diabetes Institute, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-9171-1144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LipodystrophyPhenotypeHumansPrevalence

Identifiers

PMID38900954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.